bn:02811818n
Noun Named Entity
ES
No term available
EN
CTEP is a research drug developed by Hoffmann-La Roche that acts as a selective allosteric antagonist of the metabotropic glutamate receptor subtype mGluR5, binding with nanomolar affinity and over 1000 times selectivity over all other receptor targets tested. Wikipedia
Relations
Sources
PHYSICALLY INTERACTS WITH